Oasmia proposes rights offering

Oasmia Pharmaceutical AB (SSE:OASM A), Uppsala, Sweden Business: Cancer, Drug delivery, Veterinary Date announced: 2014-11-11 Type: Rights offering To be raised: Up to SEK176.1 million ($23.8 million)...